Why OraSure Technologies, Inc.’s (OSUR) Stock Is Down 4.43%

By AAII Staff
March 11, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate OraSure Technologies, Inc. before investing.

In this article, we go over a few key elements for understanding OraSure Technologies, Inc.’s stock price such as:

  • OraSure Technologies, Inc.’s current stock price and volume
  • Why OraSure Technologies, Inc.’s stock price changed recently
  • Upgrades and downgrades for OSUR from analysts
  • OSUR’s stock price momentum as measured by its relative strength

About OraSure Technologies, Inc. (OSUR)

Before we jump into OraSure Technologies, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

OraSure Technologies, Inc. is engaged in the development and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. The Company operates through two segments: the Diagnostics segment and the Molecular Solutions segment. The Diagnostics business primarily consists of the development, manufacture, marketing, and sale of simple, easy-to-use diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Molecular Solutions business is operated by Company's subsidiaries, DNA Genotek, Diversigen, and Novosanis. The Molecular Solutions segment products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Want to learn more about OraSure Technologies, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about OraSure Technologies, Inc..

Learn More About A+ Investor

OraSure Technologies, Inc.’s Stock Price as of Market Close

As of March 11, 2024, 4:00 PM, CST, OraSure Technologies, Inc.’s stock price was $6.91.

OraSure Technologies, Inc. is down 4.43% from its previous closing price of $7.23.

During the last market session, OraSure Technologies, Inc.’s stock traded between $7.12 and $7.43. Currently, there are 73.45 million shares of OraSure Technologies, Inc. stock available for purchase.

OraSure Technologies, Inc.’s price-earnings (P/E) ratio is currently at 10.0, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 42.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

OraSure Technologies, Inc. Stock Price History

OraSure Technologies, Inc.’s (OSUR) price is currently down 3.96% so far this month.

During the month of March, OraSure Technologies, Inc.’s stock price has reached a high of $7.43 and a low of $6.83.

Over the last year, OraSure Technologies, Inc. has hit prices as high as $8.45 and as low as $4.38. Year to date, OraSure Technologies, Inc.’s stock is up 43.36%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused OraSure Technologies, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 08, 2024, there was 1 analyst who downgraded OraSure Technologies, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate OraSure Technologies, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on OraSure Technologies, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

OraSure Technologies, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about OraSure Technologies, Inc. (OSUR) by visiting AAII Stock Evaluator.

Relative Price Strength of OraSure Technologies, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 08, 2024, OraSure Technologies, Inc. has a weighted four-quarter relative price strength of -3.21%, which translates to a Momentum Score of 62 and is considered to be Strong.

Want to learn more about how OraSure Technologies, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

OraSure Technologies, Inc. Stock Price: Bottom Line

As of March 11, 2024, OraSure Technologies, Inc.’s stock price is $6.91, which is down 4.43% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like OraSure Technologies, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Est Rev: Up 5% Screen: 21.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.